181 related articles for article (PubMed ID: 31060243)
21. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
Lu F; Zhao H; Dai Y; Wang Y; Lee CH; Freeman M
Mol Cell; 2024 Jun; 84(11):2152-2165.e5. PubMed ID: 38781971
[TBL] [Abstract][Full Text] [Related]
22. The metalloprotease ADAM17 in inflammation and cancer.
Düsterhöft S; Lokau J; Garbers C
Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
[TBL] [Abstract][Full Text] [Related]
23. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
Elife; 2018 Jun; 7():. PubMed ID: 29897336
[TBL] [Abstract][Full Text] [Related]
24. Enhancing Interleukin-6 and Interleukin-11 receptor cleavage.
Lokau J; Wandel M; Garbers C
Int J Biochem Cell Biol; 2017 Apr; 85():6-14. PubMed ID: 28143719
[TBL] [Abstract][Full Text] [Related]
25. Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway.
Wang HP; Wang X; Gong LF; Chen WJ; Hao Z; Feng SW; Wu YB; Ye T; Cai YK
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4474-4481. PubMed ID: 27874952
[TBL] [Abstract][Full Text] [Related]
26. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
[TBL] [Abstract][Full Text] [Related]
27. Functional Characterization of Colon-Cancer-Associated Variants in
Dobert JP; Cabron AS; Arnold P; Pavlenko E; Rose-John S; Zunke F
Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33143292
[TBL] [Abstract][Full Text] [Related]
28. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
[TBL] [Abstract][Full Text] [Related]
29. ADAM17 Mediates Proteolytic Maturation of Voltage-Gated Calcium Channel Auxiliary α
Kadurin I; Dahimene S; Page KM; Ellaway JIJ; Chaggar K; Troeberg L; Nagase H; Dolphin AC
Function (Oxf); 2022; 3(3):zqac013. PubMed ID: 35462614
[TBL] [Abstract][Full Text] [Related]
30. ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
Schmidt S; Schumacher N; Schwarz J; Tangermann S; Kenner L; Schlederer M; Sibilia M; Linder M; Altendorf-Hofmann A; Knösel T; Gruber ES; Oberhuber G; Bolik J; Rehman A; Sinha A; Lokau J; Arnold P; Cabron AS; Zunke F; Becker-Pauly C; Preaudet A; Nguyen P; Huynh J; Afshar-Sterle S; Chand AL; Westermann J; Dempsey PJ; Garbers C; Schmidt-Arras D; Rosenstiel P; Putoczki T; Ernst M; Rose-John S
J Exp Med; 2018 Apr; 215(4):1205-1225. PubMed ID: 29472497
[TBL] [Abstract][Full Text] [Related]
31. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells.
Blanchot-Jossic F; Jarry A; Masson D; Bach-Ngohou K; Paineau J; Denis MG; Laboisse CL; Mosnier JF
J Pathol; 2005 Oct; 207(2):156-63. PubMed ID: 16041691
[TBL] [Abstract][Full Text] [Related]
32. Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells.
Cabron AS; El Azzouzi K; Boss M; Arnold P; Schwarz J; Rosas M; Dobert JP; Pavlenko E; Schumacher N; Renné T; Taylor PR; Linder S; Rose-John S; Zunke F
J Immunol; 2018 Nov; 201(10):3106-3118. PubMed ID: 30355783
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate.
Kawahara R; Granato DC; Yokoo S; Domingues RR; Trindade DM; Paes Leme AF
J Proteomics; 2017 Jan; 151():53-65. PubMed ID: 27576135
[TBL] [Abstract][Full Text] [Related]
34. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
[TBL] [Abstract][Full Text] [Related]
35. ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer.
Schumacher N; Rose-John S
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694340
[TBL] [Abstract][Full Text] [Related]
36. Molecular insights into the multilayered regulation of ADAM17: The role of the extracellular region.
Grötzinger J; Lorenzen I; Düsterhöft S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2088-2095. PubMed ID: 28571693
[TBL] [Abstract][Full Text] [Related]
37. Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity.
Düsterhöft S; Michalek M; Kordowski F; Oldefest M; Sommer A; Röseler J; Reiss K; Grötzinger J; Lorenzen I
Biochemistry; 2015 Sep; 54(38):5791-801. PubMed ID: 26348730
[TBL] [Abstract][Full Text] [Related]
38. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
Fan D; Takawale A; Shen M; Samokhvalov V; Basu R; Patel V; Wang X; Fernandez-Patron C; Seubert JM; Oudit GY; Kassiri Z
Hypertension; 2016 Oct; 68(4):937-48. PubMed ID: 27550917
[TBL] [Abstract][Full Text] [Related]
39. Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer.
Sharma A; Bender S; Zimmermann M; Riesterer O; Broggini-Tenzer A; Pruschy MN
Clin Cancer Res; 2016 Sep; 22(17):4428-39. PubMed ID: 27076628
[TBL] [Abstract][Full Text] [Related]
40. The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease.
Qian M; Shen X; Wang H
Cell Mol Neurobiol; 2016 May; 36(4):471-82. PubMed ID: 26119306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
